Clinical response and tolerability to abatacept in patients with rheumatoid arthritis previously treated with infliximab or abatacept: open-label extension of the ATTEST Study

OBJECTIVE: To assess the efficacy and safety of abatacept in biological-naive patients with rheumatoid arthritis and an inadequate response to methotrexate treated in the long-term extension (LTE) of the ATTEST trial. METHODS: Patients randomly assigned to abatacept, placebo or infliximab completing...

Descripción completa

Detalles Bibliográficos
Autores principales: Schiff, Michael, Keiserman, Mauro, Codding, Christine, Songcharoen, Suthin, Berman, Alberto, Nayiager, Sauithree, Saldate, Cristina, Aranda, Richard, Becker, Jean-Claude, Nys, Marleen, le Bars, Manuela, Reed, Diane Moniz, Poncet, Coralie, Dougados, Maxime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Group 2011
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3184243/
https://www.ncbi.nlm.nih.gov/pubmed/21914628
http://dx.doi.org/10.1136/annrheumdis-2011-200316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3184243/
https://www.ncbi.nlm.nih.gov/pubmed/21914628
http://dx.doi.org/10.1136/annrheumdis-2011-200316

Ejemplares similares